Applications in progress
Secondary Data Analysis Projects (SDAP 2025)
The Secondary Data Analysis Projects (SDAP) are designed to bring together researchers, knowledge users and data controllers to develop research projects that answer policy and/or practice-relevant questions by using secondary data.
The HRB hosted an in-person SDAP Seminar on 26 March 2025. Slides from the event are available on the call web page, which also includes a summary of the event.
The SDAP 2025 Scheme has two separate application cycles. Cycle 1 has been completed with 6 applications recommended for funding.
Cycle 2 opened for applications on 1 September 2025 and closed on 9 January 2026 at 13:00. Peer and public reviews have been completed. All applicants have been informed of the outcome, receiving feedback, with shortlisted applicants invited to submit a right of reply to peer/public review comments by 20 Apr 26. The shortlisted applications will now be considered by the international panel acknowledging public/peer review comments and applicants’ right of reply. Results will be available in early July following HRB Board approval.
Investigator-led Clinical Trials (ILCT) Programme 2025 (formerly DIFA)
The Cycle 2 submission deadline was in July 2025. 20 eligible applications were received. The Panel Meeting was held on 11/12 February 2026, with recommendations for funding approved by the HRB Board in March 2026.
The Cycle 3 submission deadline was in December 2025. 57 applications were received. Eligibility checks are completed, with eligible applications moving to peer and public review. Following peer and public review applicants will be shortlisted and invited to submit a right of reply to peer/public review comments. The shortlisted applications will be considered by the international panel acknowledging public/peer review comments and applicants’ right of reply in October 2026. Results will be available in early December 2026 following HRB Board approval.
Investigator-Led Projects (ILP) 2026
The ILP scheme aims to support highly innovative and internationally competitive investigator-led projects that can respond to existing and emerging challenges for health and social care. The ILP provides funding for clearly defined research projects in: (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR).
61 applications have been short-listed for panel review and panel meetings will take place during May.
Research in-Practice Fellowships for Health and Social Care Practitioners (RPF) 2026
Peer and public review are currently underway for 32 eligible applications, with shortlisting envisaged in mid-June. The applicant response stage for a selected number of applications shortlisted to interview stage is scheduled for mid to late June. Interviews with an international panel will take place on 2 and 3 of September.
HRCI-HRB Joint Funding Scheme 2026
The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual HRCI-registered co-funding charity. 22 applications have been short-listed for panel review and the panel meeting will take place 26 and 27 May 2026.
Collaborative Postdoctoral Fellowships Programmes (CPFP) 2026
Ten out of 40 eligible applications submitted to the HRB were shortlisted at the end of March. The leadership teams have been invited to complete a full application with a deadline of 28 May.
This is a two-stage Joint Transnational Call entitled ‘“Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)’”. The pre-proposal submission deadline was 12 January 2026 and proposals invited to the next stage for full proposal have been informed. Full proposal submission deadline was the 27th of April 2026. Full proposals are now under review.
European Rare Diseases Research Alliance (ERDERA) Joint Transnational Call (JTC) 2026
This is a two-stage Joint Transnational call entitled ‘Resolving unsolved cases in rare genetic and non-genetic diseases’. The pre-proposal submission deadline was 12 Feb 2026 and successful proposals were invited to submit a full proposal with submission due by 8 July 2026. Please ensure to submit required documentation to the HRB within the communicated deadline.
European Partnership on One Health Antimicrobial Resistance (OHAMR) 2026
The pre-proposal submission deadline was 2 February 2026 and proposals are now under review. Outcome emails are expected to be issued at the end of April 2026. The full proposal deadline will be 17 June 2026.
European Partnership on Transforming Health and Care Systems (THCS) 2026
The pre-proposal submission deadline was 2 February 2026 and proposals are now in the final stages of review. Outcome emails are expected to be issued in May 2026. The full proposal deadline will be 30 June 2026.
Conference and Event Sponsorship Scheme 2026
This scheme aims to create an opportunity to host health research related events, workshops, or conferences on the island of Ireland. Up to a maximum of €5,000 per grant is available. 28 eligible applications received to cycle 1 underwent selection by randomisation on 21 April. Recommendations for funding will go to the HRB executive team on April 28 with outcomes shared after this.
Open Calls
The All-Ireland Cancer Consortium 2026 Scheme opened at 13:00 on 25 Feb 2026 and closes on 27 May 2026 at 13:00.
An information webinar took place on 24 March at 14:00 and the recording is now available.
The AICC 2026 call will target funding to support cancer research that focuses on survivorship, for people living well with and beyond a cancer diagnosis. Cancer survivorship research covers the period from diagnosis to treatment outcome and seeks to improve care and outcomes experienced by people living with and past cancer. It will enable support of cross-border cooperation and joint efforts in cancer survivorship research to ultimately benefit people, living across the island of Ireland and beyond.
The objectives of this scheme are:
- To stimulate, engage, develop, and improve all-island, multi-disciplinary cancer research collaborations, networking, and engagement
- Prime cancer research activity aligned to the Consortium’s priority areas with specific focus for 2026 to support ‘Survivorship-Living Well With & Beyond Cancer’
- Invest in high quality, innovative cancer research pilots, mapping activities, projects and/or education initiatives.
The overall goal of the scheme is to increase the level of collaboration and innovation amongst cancer researchers and experts across the jurisdictions of Ireland and Northern Ireland. As such we expect collaboration across the two jurisdictions to form a key component of the research proposal. All applicants will be required to have cross border collaborators as co-applicants to be deemed eligible to apply e.g., a Lead Applicant from Ireland requires a Co-Applicant from Northern Ireland and vice versa.
Inclusion of people with lived experience of cancer forms a central component, hence expectation is they’ll be involved throughout and part of application design and implementation.
The Applied Partnership Awards – Women’s Health (APA-WH) 2026
The Applied Partnership Awards Women’s Health (APA-WH) 2026 deadline for applications was 1 April 2026 . Proposals are now being checked for eligibility. Eligible proposals will move on to public and peer review stage. Update emails following the public and peer review stage are expected to be sent early July 2026.
US-Ireland Research and Development Partnership Programme
This is a rolling call. The call guidance has been updated and can be found here. Check the scheme notice for full details – US-Ireland R&D Partnership Programme.
Other European research funding opportunities
See our EU funding updates story for information on more European research funding opportunities.
See also general information on the Horizon Europe and EU4Health programmes.
